News

We’re excited to announce that we’ve been awarded funding from The National Lottery Community Fund to develop a new England wide peer to peer support service for women with ovarian cancer.

We're welcoming Professor Fiona Thistlethwaite, the Medical Director of The Christie Clinical Research Facility, as the new Chair of our Scientific Advisory Board (SAB).

We’re delighted to share that Catherine Hart has been appointed as the new Chief Executive of Target Ovarian Cancer.

To mark Ethnic Minority Cancer Awareness Month, we interviewed Sbba Siddique, who was diagnosed with stage 3c ovarian cancer and is South Asian. She shares the impact of her ethnicity on her ovarian cancer journey and so much more...

Funds raised from this special event will help us continue our vital work to stop ovarian cancer devastating lives.

The West End Sings for Target Ovarian Cancer – enjoy the music of Wicked, Phantom of the Opera, Les Miserables and much more!

Annwen Jones is stepping down after 16 years as the Chief Executive of Target Ovarian Cancer.

Ali lost her friend Jo and Aunt Carol to ovarian cancer, and urges change to be made.

Nedra, Georgia’s mum, was diagnosed with stage 4 ovarian cancer in December 2017 and sadly passed away two years later. Since 2018, Georgia has taken on a challenge every year to raise both awareness and funds for Target Ovarian Cancer.

Treatment coming to an end can be a challenging time, often renewing a sense of isolation and uncertainty. For women with an ovarian cancer diagnosis, this can be exacerbated by a lack of connection to people who have had similar experiences.

We’re delighted to appoint Saswati Saha Mitra, Jo Paice and Angie Ma to the board leadership team to drive forward progress for those with ovarian cancer.

7,500 women are diagnosed with ovarian cancer every year. If diagnosed early, 9 in 10 will survive, however the reality is too many are diagnosed too late, and then just 2 in 10 are expected to survive five years or more.